Vertex snaps up Cambridge diabetes startup Semma for $950M
September 03, 2019 at 09:06 AM EDT
Vertex Pharmaceuticals has struck a deal to acquire local diabetes-focused startup Semma Therapeutics, marking another substantial pivot for the company as CEO Jeff Leiden's tenure comes to a close.
